Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bluebird Bio (BLUE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,389,982
  • Shares Outstanding, K 50,120
  • Annual Sales, $ 35,430 K
  • Annual Income, $ -335,640 K
  • 36-Month Beta 2.16
  • Price/Sales 259.03
  • Price/Cash Flow N/A
  • Price/Book 5.84

Price Performance

See More
Period Period Low Period High Performance
1-Month
171.70 +2.42%
on 06/19/18
199.70 -11.94%
on 06/04/18
-9.80 (-5.28%)
since 05/22/18
3-Month
154.45 +13.86%
on 04/04/18
199.70 -11.94%
on 06/04/18
-5.45 (-3.01%)
since 03/22/18
52-Week
85.65 +105.31%
on 08/03/17
236.17 -25.54%
on 03/13/18
+57.35 (+48.40%)
since 06/22/17

Most Recent Stories

More News
Shares of Immunogen Inc Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (IMGN , LOXO , BLUE , INSY , PTCT )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

BLUE : 175.25 (-6.46%)
IMGN : 11.88 (+1.71%)
LOXO : 181.53 (-1.10%)
Today's Research Reports on Trending Tickers: bluebird bio and Exelixis

NEW YORK, NY / ACCESSWIRE / June 21, 2018 / U.S. markets were mixed Wednesday as global trade concerns continue to be a focus. The Nasdaq and S&P 500 Index posted gains driven by deal making activities...

BLUE : 175.25 (-6.46%)
EXEL : 19.86 (-2.46%)
Blog Exposure - bluebird bio Announces Encouraging New Data from Northstar (HGB-204) and Northstar-2 (HGB-207) Studies of LentiGlobin(TM) Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

Stock Monitor: BioPharmX Post Earnings Reporting

BLUE : 175.25 (-6.46%)
Bluebird Bio Inc Set to Possibly Rebound After Yesterday's Selloff of 3.40%

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $174.71 to a high of $181.50. Yesterday, the shares fell 3.4%, which took the trading range below the 3-day low of...

BLUE : 175.25 (-6.46%)
bluebird bio Announces New Interim Data from Phase 1 (HGB-206) Study of LentiGlobin(TM) Gene Therapy in Patients with Severe Sickle Cell Disease at Annual Congress of the European Hematology Association

--- First Group C patient generating a normal total hemoglobin of 14.2 g/dL with over 60% anti-sickling HbAT87Q at 6 months -

BLUE : 175.25 (-6.46%)
bluebird bio Presents New Data from Northstar (HGB-204) and Northstar-2 (HGB-207) Studies of LentiGlobin(TM) Gene Therapy in Patients with Transfusion-Dependent B-Thalassemia at Annual Congress of the European Hematology Association

--- 8/10 of non-B(0)/B(0) patients achieving and maintaining transfusion independence for up to 3 years in Northstar (HB-204) Study -

BLUE : 175.25 (-6.46%)
Bluebird Bio Inc Rises 1.60% on Heavy Volume: Watch For Potential Pullback

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $183.60 to a high of $188.90. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high...

BLUE : 175.25 (-6.46%)
57% Sales Growth, Top-Notch Partners At Overlooked Gene and Cell Therapy Issue ORGS

Cell and gene therapy development hitting fever pitch globally as more products enter phase 3 and late-stage testing. Manufacturing remains the issue, and many companies turning to outsourced manufacturing...

BLUE : 175.25 (-6.46%)
ABEO : 15.90 (+0.63%)
AXON : 2.48 (-7.12%)
bluebird bio Announces Investor Events in June

bluebird bio, Inc. (Nasdaq: BLUE) today announced that members of the management team will present at the following upcoming investor conferences in June:

BLUE : 175.25 (-6.46%)
Celgene Presents Data on CAR T Therapy, Revlimid & Pomalyst

Biotech major Celgene presents encouraging data on its oncology drugs Revlimid, Pomalyst along with other experimental therapies at the ASCO.

CELG : 79.50 (+0.45%)
BLUE : 175.25 (-6.46%)
PRTA : 15.33 (+1.93%)
RHHBY : 27.7500 (+2.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade BLUE with:

Business Summary

Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio,...

See More

Key Turning Points

2nd Resistance Point 194.43
1st Resistance Point 190.89
Last Price 175.25
1st Support Level 182.23
2nd Support Level 177.11

See More

52-Week High 236.17
Fibonacci 61.8% 178.67
Last Price 175.25
Fibonacci 50% 160.91
Fibonacci 38.2% 143.15
52-Week Low 85.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar